Mundipharma leaving the market

Medicine update Active

Mundipharma have advised that they are leaving the Aotearoa New Zealand market.

What Pharmac is doing

Pharmac is considering multiple options for products currently supplied by Mundipharma. We're reviewing each medicine to find the best solution. One option is using our annual tender process to find new suppliers for these treatments. We are updating this page with information about what is happening with each product. 

We are working closely with Mundipharma and other suppliers to ensure as little disruption as possible for people using Mundipharma's products. 

Products we're still seeking a resolution for

Chemical name Stock available until Presentation Brand Pharmacode
Dihydrocodeine tartrate June 2025 Tab long-acting 60 mg DHC Continus 772887
Oxycodone hydrochloride June 2024 cap 5 mg Immediate release OxyNorm 2179741
Oxycodone hydrochloride June 2024 cap 10 mg immediate release OxyNorm 2179768
Oxycodone hydrochloride June 2024 cap 20 mg immediate release OxyNorm 2179776
Oxycodone hydrochloride June 2024 oral liq 5 mg per 5 ml OxyNorm 2243687
Morphine sulphate June 2025 Tab immediate-release 10 mg Sevredol 2520990
Morphine sulphate June 2025 Tab immediate-release 20 mg Sevredol 2521008

Items being delisted

Chemical name Presentation Brand Pharmacode Resolution
Timolol Eye drops 0.5%, gel forming Timoptol XE 204374

Restricted to no new patients 1 April 2023.

To be delisted 1 March 2024

Information for people who use Timoptol XE

Dorzolamide hydrochloride Eye drops 2% Trusopt 285226

Restricted to no new patients 1 April 2023.

To be delisted 1 March 2024

Information for people who use Trusopt

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is. 

Sign up to our email list for regular emails about supply issues and more(external link)